Non regulatory

Non regulatory

Navamedic ASA: Navamedic extends its business into Germany together with Evolsin Medical

Navamedic ASA launches Eroxon® in Denmark

Navamedic Welcomes CHMP’s Positive Review of Mysimba’s Cardiovascular Safety

Navamedic launches Eroxon[®] in Finland

Navamedic wins joint Nordic antibiotics tender

Navamedic announces an exclusive agreement with Alex Therapeutics for the development of a Companion App to aid in the treatment of Parkinson’s Disease